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Overview
Statement of the Problem
Infection control breaches can occur in any health care setting and can result in the transmission of hepatitis 
B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and other viral and bacterial 
infections. According to the Centers for Disease Control and Prevention (CDC) more than 50 outbreaks of blood 
borne pathogens have occurred in the United States due to unsafe injection practices since 2001. In 2013, one 
notable outbreak involving nine cases of acute Hepatitis B associated with a spinal care center occurred in South 
Carolina. Nationally some of the most commonly identified breaches in safe injection practices involve the use 
of medication from a multi-dose vial or use of a new needle but the same syringe for more than one patient.
Injection safety, or safe injection practice, are recommended standards for performing injections in an optimally 
safe manner for patients and healthcare personnel. A new and clean needle, syringe, or lancet must be used 
whenever administering injection medications, IV fluids, performing glucose monitoring or for any procedure 
that may result in blood or body fluid contamination.
How to use this Toolkit
The Injection Safety Toolkit for Health Care Providers was originally developed by the DHEC Health Care 
Associated Infections Section of the Division of Acute Disease Epidemiology in response to needs identified by 
South Carolina long-term care facilities in a survey of safe injection practices. However, safe injection practices 
are relevant for providers in all care settings. The Toolkit includes resources from CDC, the Occupational Safety 
and Health Administration (OSHA) and the Safe Injection Practices Coalition (SIPC) One and Only Campaign, 
a public health campaign developed to raise awareness among patients and healthcare providers about safe 
injection practices. 
Health care facilities are encouraged to maintain safe injection standards, to assure ongoing training for workers, 
and to incorporate recommendations in this toolkit, with other professional resources, to assist in implementing 
or enhancing an injection safety campaign and safe injection practices. The reference section and the links to 
the One and Only Campaign, and the Healthcare Infection Control Practices Advisory Committee (HICPAC) found 
at the CDC website provide additional information about practice standards and training. This toolkit does not 
replace published standards and regulations.
Use the resources to educate all health care providers in your facility about safe injection practices and infection 
prevention strategies. Share the documents and links with all workers who perform any exposure prone 
procedures, including blood glucose monitoring, to support periodic, on-site training and to orient new staff.
We hope you find this toolkit useful and appreciate any feedback on the materials including which resources 
are most helpful and which areas need improvement. Share this information with your staff and colleagues to 
promote safe injection practices at your worksite. For input or questions, please contact:
The DHEC Healthcare-Associated Infections Section phone: 803-898-0861
For more information visit: http://www.scdhec.gov/Health/FHPF/
This toolkit was developed by Alisha O’Connell, B.A./B.S., MPH candidate, Graduate Assistant for HAI section, and Kate Patterson, Program 
Manager, HAI Section  under the guidance of Linda Bell, M.D., State Epidemiologist. Revised 2017, by Natasha Wright, RN MSN. 
2
Table of Contents
Educational Resources         4
	 Education	Overview        5
	 Impact	of	Unsafe	Medication	Injections	Infographic   6
	 Dangerous	Misperceptions       8
	 Fast	Facts          9
	 Frequently	Asked	Questions	(FAQs)      13
OSHA National Standards        20
	 OSHA	Bloodborne	Pathogens	Standard	Fact	Sheet    21
	 OSHA	Personal	Protective	Equipment	(PPE)     23
Guidance for Blood Glucose Monitoring and Insulin Administration  25
	 Diabetes	and	Viral	Hepatitis       26
	 CDC	Clinical	Reminder	Insulin	Pens      27
	 *60	Second	Check	Lancing	Device      28
	 *60	Second	Check	Insulin	Pen       29
Training           30
	 Safe	Injection	Training	and	Oversight	for	Healthcare	Staff   31
	 One	Needle,	One	Syringe,	Only	One	Time	Presentation   32
Promotional Materials         42
	 Injection	Safety	Guidelines	Pocket	Card     43
	 Injection	Safety	Checklist        44
	 It’s	Elementary	Poster        45
Multimedia Links          46
3
Educational Resources
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Education
Breaches in injection safety practices are a serious health care issue. Improper injection safety practices have 
resulted in clusters of blood borne pathogens, large-scale patient call backs, mass post-exposure prophylaxis and 
follow up. A preventable public health risk and liability for providers.
This public health problem can be addressed by assuring adequate training of all health care workers who 
perform any type of injection procedures to include blood glucose monitoring, line flush or administration of 
injectable medications or medical procedures.
Health care facilities are encouraged to assure that all health care workers engage in a minimum of annual 
training in safe injection standards, and that all new workers are confirmed to have received training in injection 
safety. This Toolkit provides references to support training and education about safe infection practices and 
infection prevention strategies. The reference section and the links to the One and Only Campaign, and the 
Healthcare Infection Control Practices Advisory Committee (HICPAC) found at the CDC website provide additional 
information about practice standards and training. Share the documents and links with all workers who perform 
any exposure-prone procedures, including blood glucose monitoring, to support periodic, on-site training and to 
orient new staff. This toolkit does not replace published standards and regulations.
Injections and infusions of parenteral medication likely represent the most common invasive procedure across 
all healthcare facilities.  The achieving the goal of injections without infections requires well-trained healthcare 
providers at all levels to adhere to Standard Precautions to minimize risk of infection to patients and healthcare 
personnel.  Unsafe infections globally contributes to 30% of new Hepatitis B infections, 40% of new Hepatitis C 
infections and 5% of new HIV infections.
Unsafe infection Practices
• Reuse of syringes
• For multiple patients (“direct reuse”)
• Examples include injecting through IV tubine, insulin pens and narcotics syringes that were subjected 
to tampering
• To access shared medications
• “Indirect reuse” a.k.a. “double dipping”
• Mishandling and inappropriate sharing of medication vials and containers
• Administration of medication from a single-dose vial to multiple patients
• Intravenous solutions bags used as a common source of supply for multiple patients
In a survey of 5,500 U.S. healthcare professionals, 1% “sometimes or always” reused a syringe on a second 
patient or reused a multi-dose vial for additional patients after accessing it with a used syringe. 6% reported 
using single-dose vials for more than one patient.
CDC Standard Precautions, 2007: Safe Injection Practices
• Use aseptic technique when preparing and administering medications
• Never administer medications from the same syringe to multiple patients
• Do not reuse a syringe to enter a medication vial or solution
• Do not administer medications from single-dose vials or intravenous solution bags to more than one patient
• Limit the use of multi-dose vials and dedicate them to a single patient whenever possible.
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THE IMPACT OF UNSAFE MEDICAL INJECTIONS IN THE U.S.        . . 
Unsafe Injection Practices Have Devastating Consequences1 
Follow proper infection control practices and 
maintain aseptic technique during the 
preparation and administration of injected 
medications (e.g., perform hand hygiene). 
Never administer medications from the same 
syringe to more than one patient, even if the 
needle is changed. 
Never enter a vial with a used syringe or 
needle. 
Do not use medications packaged as 
single-dose or single-use for more than one 
patient. 
Do not use bags of intravenous solution as a 
common source of supply for more than one 
patient. 
Limit the use of multi-dose vials and dedicate 
them to a single patient whenever possible. 
Always use facemasks when injecting material 
or inserting a catheter into the epidural or 
subdural space. 
Syringe reuse and misuse of medication vials 
have resulted in dozens of outbreaks and
THE NEED TO ALERT MORE THAN 
150,000 PATIENTS... 
...to seek testing for 
bloodborne pathogens such as 
HEPATITIS B, HEPATITIS C 
AND HIV, 2 and have led to... 
In just one clinic, syringe reuse to access medication vials for multiple patients 
resulted in an outbreak and one of the largest public health alerts in U.S. history. 
Patient illness 
and death 
Loss of 
clinician licenses 
Legal charges/ 
malpractice suits 
Criminal charges 
Steps Every Healthcare 
Provider Should Take 
Outbreaks Occur in a 
Variety of Settings
= 1 million
 1000 
= patients
 notiﬁed 
50,000
PEOPLE EXPOSED 
TO INFECTION
$16~$20 
MILLION 
IN COSTS 
REV
OK
ED
REV
OK
ED 
Hospitals 
Primary care clinics 
Pediatric offices 
Outpatient surgical centers 
Pain clinics 
Imaging facilities 
Oncology clinics 
Dental clinics 
Health fairs 
Injection Safety is
Every Provider’s 
Responsibility 
for 
for 
for 
The Safe Injection Practices Coalition (SIPC) is a partnership of healthcare-related organizations led by 
the Centers for Disease Control and Prevention. The SIPC developed the One & Only Campaign—a public 
public health effort to eliminate unsafe medical injections by raising awareness of safe injection 
practices. For a list of SIPC Partners, more information about the Campaign, and to view additional 
resources including videos and other materials, please visit OneandOnlyCampaign.org 
For the latest news and updates, follow us on Twitter @injectionsafety and 
Facebook/OneandOnlyCampaign. 
This material was developed by CDC. The One & Only Campaign is made possible by a partnership between the CDC Foundation and Lilly USA, LLC. 
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-FOOTNOTES 
1 	 Centers for Disease Control and Prevention. (August 24, 2012). Injection Safety Information for Providers. In 
CDC.gov. Retrieved October 10 2012, from http://www.cdc.gov/injectionsafety/providers.html. 
2 	 Guh, Alice Y. MD, MPH; Thompson, Nicola D. PhD; Schaefer, Melissa K. MD; Patel, Priti R. MD, MPH; Perz, Joseph F. 
DrPH. Patient Notification for Bloodborne Pathogen Testing due to Unsafe Injection Practices in the US Health Care 
Settings, 2001 2011. Medical Care Journal, May2012. 
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DANGEROUS 
MISPERCEPTIONS
Here are some examples of dangerous 
misperceptions about safe injection practices.
Myth Truth
Once they are used, both the needle and syringe are 
contaminated and must be discarded. A new sterile needle 
and a new sterile syringe should always be used for each 
patient and to access medication vials.
Changing the needle makes a 
syringe safe for reuse.
Everything from the medication bag to the patient's IV 
catheter is a single interconnected unit. Distance from the 
patient, gravity, or even infusion pressure do not ensure that 
small amounts of blood won't contaminate the syringe once 
it has been connected to the unit. Syringes should never be 
reused for more than one patient or to access medication vials.
Syringes can be reused as long as an 
injection is administered through an 
intervening length of IV tubing.
If you don't see blood in the IV 
tubing or syringe, it means that 
those supplies are safe for reuse.
Pathogens including hepatitis C virus, hepatitis B virus, 
and HIV can be present in sufficient quantities to produce 
infection without any visible blood.
Single-dose vials with large volumes 
that appear to contain multiple 
doses can be used for more than  
one patient.
Single-dose vials should not be used for more than one 
patient regardless of the vial size.
Injection Safety is 
Every Provider’s Responsibility!
www.oneandonlycampaign.org 8
For injection safety guidelines, checklists, frequently asked questions, and other resources 
visit OneAndOnlyCampaign.org. For the latest news and updates follow us on  
Twitter @injectionsafety and Facebook/OneandOnlyCampaign  
FAST FACTS:  
UNSAFE INJECTION PRACTICES
The Impact of Unsafe Injection Practices
Although safe injection practices are basic infection control measures, they are not always followed.
§ More than 150,000 patients have been impacted by unsafe injection practices since 2001. Breakdowns
in proper infection control often involve providers reusing needles, syringes or single-dose medication
vials, all of which are meant for one patient and one procedure. These breaches can cause irreparable
damage exposing patients to bloodborne illnesses, such as hepatitis and HIV, and to life-threatening
bacterial infections. Although safe injection practices represent very basic infection control measures,
CDC routinely investigates outbreaks associated with deficient practices.
§ As highlighted in a recent report from the U.S. Government Accountability Office (GAO) these data show
that from 2001 through 2011, there were at least 18 outbreaks of viral hepatitis associated with unsafe
injection practices in ambulatory settings, such as physician offices or ambulatory surgical centers (ASC).
This does not include outbreaks of bacterial infections.
§ A table from the Centers for Disease Control and Prevention includes examples of recent outbreaks and
patient notification events occurring in a variety of outpatient settings, including primary care clinics,
pediatric offices, ambulatory surgical centers, pain remediation clinics, imaging facilities, oncology clinics,
and even health fairs: www.OneAndOnlyCampaign.org/outbreaks-table
§ The documented number of patients affected by unsafe injections likely represents only the tip of the
iceberg. Some diseases and infections spread through unsafe infection practices can take years to show
up. By the time symptoms arise, the disease or infection can cause irreparable damage.
§ Consequences of unsafe injection practices include: infection transmission to patients, notification of
thousands of patients of possible exposure to bloodborne pathogens, referral of providers to licensing
boards for disciplinary action, and malpractice suits filed by patients.
Lapses in Basic Infection Control
Many documented lapses in basic infection control practices involved healthcare providers reusing 
syringes when giving patients medication, or when drawing up medication from vials meant for  
only one use.  
§ Known outbreaks indicate that several procedures put patients most at risk:
• The administration of sedatives and anesthetics for surgical, diagnostic, and pain
management procedures
• The administration of IV medications for chemotherapy, imaging studies, cosmetic
procedures, and alternative medicine therapies (e.g., contrast medium)
• The use of saline from an IV administration bag to flush IV lines and catheters
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§ The following practices are dangerous and have resulted in disease transmission:
• Using the same syringe to administer medication to more than one patient, even if the needle was
changed or the injection was administered through an intervening length of intravenous (IV) tubing 1,2
• Accessing medication with a syringe that has already been used to administer medication to a patient,
then reusing the contaminated medication for another patient 3,4,5,6
• Using medications packaged as single-dose or single-use for more than one patient 7,8,9
• Failing to use aseptic technique when preparing and administering injections 10,11,12
§ A single-dose vial should only be used for one patient and any remaining contents should be discarded.
There are options for working with high-quality pharmacies or pharmaceutical compounding companies
when customized doses are needed. In such cases, it is critical that the pharmacy or company strictly
adheres to USP 797 standards.
Cases and Consequences of Unsafe Injection Practices
§ ARIZONA: In April 2012, an
outbreak of methicillin-
resistant Staphylococcus
aureus (MRSA) occurred
at an outpatient pain
management clinic in
Arizona, where patients
had been injected with
a diluted contrast medium for radiologic
imaging. Due partly to the difficulty in
obtaining a reliable supply of a low-
concentration contrast medium, the clinic staff
prepared two batches of contrast medium,
taken from a single-dose vial, and diluted with
saline solution. One batch was used for all
of the morning’s patients and a second was
used in the afternoon. All of the patients who
contracted MRSA received an injection on the
same day from the same batch of medication.
Three patients were treated for severe
infections, requiring hospitalization ranging
from 9 – 41 days.14  A fourth patient died from
multiple drug overdose but invasive MRSA
infection could not be ruled out.
§ DELAWARE: In March of 2012, seven
patients who had received joint
injections at an outpatient orthopedic
clinic in Delaware contracted a
methicillin-susceptible Staphylococcus
aureus. The only breach of safe practice
that had taken place at the clinic was
the reuse of single-dose vials (SDVs) of
the anesthetic bupivacaine for multiple patients.
Clinic staff had until recently been using 10 mL
SDVs for single-patient use. However, a national
drug shortage disrupted this supply and
prompted the use of 30 mL SDVs for multiple
patients, with staff drawing from the same vial
until it was empty and occasionally storing it
overnight for use the following day. The infected
patients required an average hospital stay of six
days to combat the infection. 13
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§ NEVADA: A 2008 outbreak of
hepatitis C at an endoscopy
clinic in Nevada occurred
because syringes used to
access medication vials were
reused for multiple patients. The
resulting public health notification
of approximately 50,000 people was the
largest of its kind in United States healthcare.
The Southern Nevada Health District
estimated total public health costs including
investigation, testing, and medical counseling
at $16-$21 million. The doctor and two
nurses involved in the outbreak face a loss of
livelihood and reputation, as well as criminal
charges that their malpractice insurance does
not cover.
§ NEW JERSEY: A 2009 outbreak of
Hepatitis B at an oncology practice
occurred as a result of a variety of
unsafe injection practices. These
practices included reuse of single-
dose vials for multiple patients and
use of a common source saline bag
for multiple patients. The resulting
public health notification affected 4,600
patients, and 29 cancer patients were infected
with hepatitis B as a result of this outbreak. The
State of New Jersey revoked the medical license
of the physician who operated the oncology
practice in 2011.
§ SOUTH CAROLINA: A 2013
outbreak of hepatitis B
associated with a pain
management center occured
where breaches in infection
control practices were
identified. These included lapses
in safe injection practices, poor
record keeping of equipment
and medication, and lack of
written infection control and
bloodborne pathogen exposure
policies and plans. There was
insufficient evidence to
implicate a specific breach as
the source of transmission. The
local health department notified
534 at-risk patients that received
injections at the facility with 9
outbreak-related cases.15
                                       In 2013, 
an outbreak of nine cases of 
acute hepatitis B associated 
with  spinal care center was 
identi ed. An investigati  
revealed brea hes in infection 
control practices had occurred 
at the facility. These in luded 
lapses in safe injection practices, 
ina equate record keeping of 
equipment and medicatio , 
lacking written Infection c ntrol 
and blood borne pathogen 
exposur  policies and plans. 
A s e i c source of the 
inf ctions was not identi ed 
but cas s wer  genetically and 
epidemiologically linked. The 
local health department noti ed 
534 at-risk p i nts that had 
received injections at the facility.
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For injection safety guidelines, checklists, frequently asked questions, and other resources 
visit OneAndOnlyCampaign.org. For the latest news and updates follow us on  
Twitter @injectionsafety and Facebook/OneandOnlyCampaign  
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The FAQs are organized in 
the following sections:
•	 General
•	 Medication	Preparation
•	 	Medication	
Administration
•	 	Single-dose/Single-use	
vials
•	 Multi-dose	vials
•	 References
FAQs
FREQUENTLY ASKED QUESTIONS (FAQs) 
REGARDING SAFE PRACTICES FOR MEDICAL INJECTIONS
Background
Injection safety, or safe injection practices, is a set of measures taken to perform injections in an optimally 
safe manner for patients, healthcare personnel, and others. 
The Standard Precautions section of the 2007 Guideline for Isolation Precautions provides evidence-
based recommendations for safe injection practices and reflects the minimum standards that healthcare 
personnel should follow to prevent transmission of infections in healthcare settings. 
Despite these recommendations, outbreaks and patient notifications resulting from healthcare personnel 
failing to adhere to Standard Precautions and basic infection control practices continue to be reported. 
Unsafe injection practices that have resulted in disease transmission have most commonly included:  
• 	Using	the	same	syringe	to	administer	medication	to	more	than	one	patient,	even	if	the	needle	was
changed or the injection was administered through an intervening length of intravenous (IV) tubing1,2;
•	 	Accessing	a	medication	vial	or	bag	with	a	syringe	that	has	already	been	used	to	administer
medication to a patient, then reusing contents from that vial or bag for another patient3-6;
•	 	Using	medications	packaged	as	single-dose	or	single-use	for	more	than	one	patient7-9;
•	 Failing	to	use	aseptic	technique	when	preparing	and	administering	injections10-12
 For these reasons, CDC reminds healthcare personnel of the following practices that are critical for
patient safety: 
•	 	Follow	proper	infection	control	practices	and	maintain	aseptic	technique	during	the	
preparation and administration of injected medications (e.g., perform hand hygiene). 
•	 	Never	administer	medications	from	the	same	syringe	to	more	than	one	patient,	even	if	the	
needle is changed. 
•	 Never	enter	a	vial	with	a	used	syringe	or	needle.	
•	 Do	not	use	medications	packaged	as	single-dose	or	single-use	for	more	than	one	patient.	
•	 	Do	not	use	bags	of	intravenous	solution	as	a	common	source	of	supply	for	more	than	one	patient.	
•	 Limit	the	use	of	multi-dose	vials	and	dedicate	them	to	a	single	patient	whenever	possible.	
•	 	Always	use	facemasks	when	injecting	material	or	inserting	a	catheter	into	the	epidural	or
subdural	space.
The	following	FAQs	summarize	inquiries	received	by	CDC	from	healthcare	personnel	regarding	safe	use	
of needles, syringes, and injectable medications in patient care settings. Wherever possible we have 
attempted to provide examples of outbreaks or patient notification incidents that support the guidance 
offered	in	these	FAQs.	An	extensive	reference	list	is	included	at	the	end	of	this	document.	
These	FAQs	are	not	intended	as	a	comprehensive	resource	for	all	safe	injection	practices	and	additional	
considerations may be necessary for certain clinical scenarios or settings. Healthcare personnel are 
encouraged to consult the Standard Precautions section of the 2007 Guideline for Isolation Precautions 
to ensure that their practices adhere to the basic principles of infection control and aseptic technique. 
Additional	information	applicable	to	specific	clinical	settings	or	procedures	may	be	available	from	
professional	organizations.	
A	Note	about	 
Pharmacy Settings
While the use of aseptic 
technique when preparing 
and administering injectable 
medications is applicable 
to all healthcare settings, 
including pharmacy areas, 
these FAQs are not intended 
to reflect the standards and 
recommended practices for 
handling medication vials and 
related products in pharmacy 
settings—these should be 
determined in accordance 
with the state boards of 
pharmacy, the United States 
Pharmacopeia (USP), the 
Drug Enforcement Agency 
(DEA), and the Food and 
Drug Administration (FDA). 
Please visit http://www.
cdc.gov/injectionsafety/
providers/provider_faqs.
html for updates or additional
information. Published 
March 1, 2011. 
Source: Centers for Disease Control and Prevention, December 2010, http://www.cdc.gov/injectionsafety/providers/provider_faqs.html
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GENERAL QUESTIONS
1. What is injection safety?
Injection safety, or safe injection practices, is a set of measures taken to perform injections in an optimally
safe	manner	for	patients,	healthcare	personnel,	and	others.	A	safe	injection	does	not	harm	the	recipient,
does not expose the provider to any avoidable risks, and does not result in waste that is dangerous for
the community (e.g., through inappropriate disposal of injection equipment)13. Injection safety includes
practices intended to prevent transmission of infectious diseases between one patient and another, or
between a patient and healthcare provider, and also to prevent harms such as needlestick injuries.
2. What	is	aseptic	technique?
In this context, aseptic technique refers to the manner of handling, preparing, and storing of medications
and injection equipment/supplies (e.g., syringes, needles and IV tubing) to prevent microbial
contamination.	See	additional	FAQs	below	for	details	on	aseptic	technique.
3.		What	are	some	of	the	unsafe	injection	practices	that	have	resulted	in	transmission	of
pathogens?
The most common practices that have resulted in transmission of hepatitis C virus (HCV), hepatitis B virus 
(HBV) and/or other pathogens include: 
• 	Using	the	same	syringe	to	administer	medication	to	more	than	one	patient,	even	if	the	needle	was
changed or the injection was administered through an intervening length of intravenous (IV) tubing1,2;
• 	Accessing	a	medication	vial	or	bag	with	a	syringe	that	has	already	been	used	to	administer
medication to a patient, then reusing contents from that vial or bag for another patient3-6;
• Using	medications	packaged	as	single-dose	or	single-use	for	more	than	one	patient7-9;
• Failing	to	use	aseptic	technique	when	preparing	and	administering	injections10-12.
4. 	What	are	some	procedures	that	have	been	associated	with	unsafe	injection	practices?
Unsafe injection practices that put patients at risk for HBV, HCV and other infections have been identified
during various types of procedures. Examples include:
• 	Administration	of	sedatives	and	anesthetics	for	surgical,	diagnostic,	and	pain	management
procedures;
• 	Administration	of	IV	medications	for	chemotherapy,	cosmetic	procedures,	and	alternative	medicine
therapies;
• Use	of	saline	solutions	to	flush	IV	lines	and	catheters;
• Administration	of	intramuscular	(IM)	vaccines.
The medications used in these procedures were in single-dose or single-use vials, multi-dose vials, and bags. 
What they had in common was the vials or bags were used for more than one patient and were entered with 
a syringe that had already been used for a patient; or the syringe itself was used for more than one patient. 
5. 	Can	some	of	these	unsafe	injection	practices	also	result	in	transmission	of	bacterial
infections?
Yes. These unsafe injection practices put patients at risk for bacterial, fungal, viral, and parasitic infections.
6. 	Is	it	acceptable	to	visually	inspect	syringes	to	determine	whether	they	are
contaminated	or	can	be	used	again?
No. Just because blood or other material is not visible in a used syringe or IV tubing does not mean the item 
is free from potentially infectious agents. Pathogens including HBV, HCV, and human immunodeficiency 
Source: Centers for Disease Control and Prevention, December 2010, http://www.cdc.gov/injectionsafety/providers/provider_faqs.html
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virus (HIV) can be present in sufficient quantities to produce infection in the absence of visible blood. Similarly, 
bacteria and other microbes can be present without clouding or other visible evidence of contamination. 
All	used	injection	supplies	and	materials	are	potentially	contaminated	and	should	be	discarded.
7. How can healthcare personnel ensure that injections are performed correctly?
To help ensure that all healthcare personnel understand and adhere to safe injection practices, we
recommend the following:
1.  Designate someone to provide ongoing oversight for infection control issues;
2.  Develop written infection control policies;
3.  Provide training;
4.  Conduct quality assurance assessments
MEDICATION PREPARATION QUESTIONS
1. How should I draw up medications?
Parenteral medications should be accessed in an aseptic manner. This includes using a new sterile syringe
and sterile needle to draw up medications while preventing contact between the injection materials and
the non-sterile environment. Proper hand hygiene should be performed before handling medications and
the rubber septum should be disinfected with alcohol prior to piercing it.
2. Where should I draw up medications?
Medications	should	be	drawn	up	in	a	designated	clean	medication	area	that	is	not	adjacent	to	areas	where
potentially contaminated items are placed. Examples of contaminated items that should not be placed in or
near the medication preparation area include: used equipment such as syringes, needles, IV tubing, blood
collection tubes, needle holders (e.g., Vacutainer® holder), or other soiled equipment or materials that have
been used in a procedure. In general, any item that could have come in contact with blood or body fluids
should not be in the medication preparation area.
3. 	Is	it	acceptable	to	leave	a	needle	inserted	in	the	septum	of	a	medication	vial	for
multiple medication draws?
No.	A	needle	should	never	be	left	inserted	into	a	medication	vial	septum	for	multiple	uses.	This	provides	a	
direct route for microorganisms to enter the vial and contaminate the fluid.
4. 	Is	it	acceptable	to	leave	a	needle	inserted	in	the	septum	of	a	medication	vial	for
multiple medication draws?
The safest practice is to always enter a medication vial with a sterile needle and sterile syringe. There has 
been at least one outbreak attributed to healthcare personnel using a common needle and syringe to 
access multiple multi-dose vials for the purpose of combining their contents into a single syringe14. If one 
vial becomes contaminated, this practice can spread contamination to the others, prolonging presence of 
the pathogen and increasing the potential for disease transmission. Syringe reuse in this fashion may also 
have been a factor in additional outbreaks9. 
While it is not recommended to use the same needle and syringe to enter more than one medication vial 
because of the risks described above, there are circumstances where more than one vial may need to be 
entered with the same syringe and needle (e.g., when reconstituting medications or vaccines). In these 
circumstances, aseptic technique must be followed and reconstitution should be performed in a designated 
clean medication area that is not adjacent to areas where potentially contaminated items are placed.
Source: Centers for Disease Control and Prevention, December 2010, http://www.cdc.gov/injectionsafety/providers/provider_faqs.html
15
MEDICATION ADMINISTRATION QUESTIONS
1. 	Is	it	acceptable	to	use	the	same	syringe	to	give	an	injection	to	more	than	one	patient	if	I
change	the	needle	between	patients?
No. Once they are used, the syringe and needle are both contaminated and must be discarded. Use a new 
sterile syringe and needle for each patient.
2. 		Is	it	acceptable	to	use	the	same	syringe	to	give	an	injection	to	more	than	one	patient	if	I
change	the	needle	between	patients	and	I	don’t	draw	back	before	injecting?
No.	A	small	amount	of	blood	can	flow	into	the	needle	and	syringe	even	when	only	positive	pressure	is	
applied outward. The syringe and needle are both contaminated and must be discarded. 
3. 		If	I	used	a	syringe	only	to	inject	medications	into	an	IV	tubing	port	that	is	several	feet
away	from	the	patient’s	IV	catheter	site,	is	it	acceptable	to	use	the	same	syringe	for
another patient?
No.	Everything	from	the	medication	bag	to	the	patient’s	catheter	is	a	single	interconnected	unit.	All	of	
the components are directly or indirectly exposed to the patient’s blood and cannot be used for another 
patient.	A	syringe	that	intersects	through	ports	in	the	IV	tubing	or	bags	also	becomes	contaminated	and	
cannot be used for another patient. Separation from the patient’s IV by distance, gravity and/or positive 
infusion pressure does not ensure that small amounts of blood are not present in these items. 
4. 	Is	it	acceptable	to	reuse	a	syringe	and/or	needle	to	enter	a	medication	vial	for	the
same	patient	if	the	medication	vial	and	the	syringe	will	be	discarded	at	the	end	of	the
procedure	and	not	used	for	subsequent	patients?
The safest practice is to always enter a medication vial with a sterile needle and sterile syringe, even when 
obtaining additional doses of medication for the same patient. This adds an extra layer of safety in case, 
for some reason, the medication vial is not discarded at the end of the procedure as it should be and is 
inadvertently used on a subsequent patient. 
There have been multiple outbreaks resulting from healthcare personnel reusing syringes to access 
medications for a single patient and then using contents from that vial or bag for subsequent patients3-4. 
In some of these outbreaks, healthcare personnel believed that they were being careful and their intention 
was to discard the vial or bag at the end of the procedure; however, this did not always occur and contents 
from the vial or bag were inadvertently used for subsequent patients5. 
5. 		Is	it	acceptable	to	use	the	same	syringe	and/or	needle	to	administer	multiple	injections
to	the	same	patient	(e.g.,	in	the	case	of	numbing	a	large	area	of	skin	or	to	provide
incremental	doses	of	intravenous	medication)?
The safest practice is for a syringe and needle to be used only once to administer a medication to a single 
patient, after which the syringe and needle should be discarded. This practice prevents inadvertent reuse of 
the syringe and protects healthcare personnel from harms such as needlestick injuries. 
However, when this is not feasible (e.g., when administration of incremental doses to a single patient from 
the same syringe is an integral part of the procedure), reuse of the same syringe and needle for the same 
patient should occur as part of a single procedure with strict adherence to aseptic technique. In such 
situations it is essential that the syringe never be left unattended and that it be discarded immediately at 
the end of the procedure. 
There have been situations of disease transmission and recent patient notification events in the setting of 
unintentional syringe reuse after a syringe was not immediately discarded following use on a patient2,15. 
Please visit http://www.cdc.gov/injectionsafety/providers/provider_faqs.html  for updates or additional 
information.	Published	March	1,	2011.	
Source: Centers for Disease Control and Prevention, December 2010, http://www.cdc.gov/injectionsafety/providers/provider_faqs.html
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QUESTIONS	ABOUT	SINGLE-DOSE/SINGLE-USE	VIALS
1. What	is	a	single-dose	or	single-use	vial?
A	single-dose	or	single-use	vial	is	a	vial	of	liquid	medication	intended	for	parenteral	administration	(injection	
or infusion) that is meant for use in a single patient for a single case/procedure/injection. Single-dose or 
single-use vials are labeled as such by the manufacturer and typically lack an antimicrobial preservative. 
2. 	Can	single-dose	or	single-use	vials	be	used	for	more	than	one	patient?
No. Vials that are labeled as single-dose or single-use should be used for a single patient and single case/
procedure/injection. There have been multiple outbreaks resulting from healthcare personnel using single-
dose or single-use vials for multiple patients3,6-9.
Even if a single-dose or single-use vial appears to contain multiple doses or contains more medication than 
is needed for a single patient, that vial should not be used for more than one patient nor stored for future 
use on the same patient. 
To prevent unnecessary waste or the temptation to use contents from single-dose or single-use vials for 
more than one patient, healthcare personnel should select the smallest vial necessary for their needs when 
making purchasing decisions. 
3. 		How	many	times	may	individual	single-dose	or	single-use	vials	be	entered	for	a	single
patient?
The safest practice is to enter a single-dose or single-use vial only once so as to prevent inadvertent 
contamination of the vial and infection transmission. Single-dose or single-use vials should be used for a single 
patient and a single case/procedure/injection. Therefore, they should require only a single entry into the vial. 
However, in certain situations, healthcare personnel may believe that drawing the entire contents of the vial 
into a single syringe will not allow for safe and accurate titration of dosage (e.g., pediatric dosing during a 
surgical procedure). In these circumstances, healthcare personnel must consider the risk of repeated entry 
into a single-dose or single-use vial for that single patient/procedure. 
If the single-dose or single-use vial will be entered more than once for a single patient as part of a single 
procedure, it should be with a new needle and new syringe, and the vial must be discarded at the end of 
the procedure and not stored for future use. 
4.			Is	it	acceptable	to	combine	(pool)	leftover	medication	from	single-dose	or	single-use	vials?
No. Do not combine (pool) leftover contents of single-dose or single-use vials or store single-dose or single-
use vials for later use. Single-dose or single-use vials are intended for use on a single patient for a single
case/procedure. There have been outbreaks resulting from pooling of contents of single-dose or single-use
vials and/or storage of contents for future use8.
5. When	should	single-dose	or	single-use	vials	be	discarded?
Medication	vials	should	always	be	discarded	whenever	sterility	is	compromised	or	questionable.
In addition, the following recommendations are made for handling of single-dose or single-use vials: 
•	 	If	a	single-dose	or	single-use	vial	has	been	opened	or	accessed	(e.g.,	needle-punctured)	the	vial	should
be discarded according to the time the manufacturer specifies for the opened vial or at the end of the 
case/procedure for which it is being used, whichever comes first. It should not be stored for future use. 
• 	If	a	single-dose	or	single-use	vial	has	not	been	opened	or	accessed	(e.g.,	needle-punctured),	it
should be discarded according to the manufacturer’s expiration date. Please visit http://www.cdc.
gov/injectionsafety/providers/provider_faqs.html for updates or additional information. Published
March	1,	2011.
Source: Centers for Disease Control and Prevention, December 2010, http://www.cdc.gov/injectionsafety/providers/provider_faqs.html
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QUESTIONS	ABOUT	MULTI-DOSE	VIALS
1. What	is	a	multi-dose	vial?
A	multi-dose	vial	is	a	vial	of	liquid	medication	intended	for	parenteral	administration	(injection	or	infusion)
that	contains	more	than	one	dose	of	medication.	Multi-dose	vials	are	labeled	as	such	by	the	manufacturer
and typically contain an antimicrobial preservative to help prevent the growth of bacteria. The preservative
has no effect on viruses and does not protect against contamination when healthcare personnel fail to
follow safe injection practices.
2. Can	multi-dose	vials	be	used	for	more	than	one	patient?	How?
Multi-dose	vials	should	be	dedicated	to	a	single	patient	whenever	possible.
If multi-dose vials must be used for more than one patient, they should not be kept or accessed in the 
immediate patient treatment area. This is to prevent inadvertent contamination of the vial through direct 
or indirect contact with potentially contaminated surfaces or equipment that could then lead to infections 
in subsequent patients. If a multi-dose vial enters the immediate patient treatment area, it should be 
dedicated to that patient only and discarded after use. 
3. What are examples of the “immediate patient treatment area”?
Examples of the immediate patient treatment area include patient rooms or bays, and operating rooms.
4. When	should	multi-dose	vials	be	discarded?
Medication	vials	should	always	be	discarded	whenever	sterility	is	compromised	or	questionable.
In addition, the United States Pharmacopeia (USP) General Chapter 79716 recommends the following for 
multi-dose vials of sterile pharmaceuticals: 
• 	If	a	multi-dose	has	been	opened	or	accessed	(e.g.,	needle-punctured)	the	vial	should	be	dated	and
discarded within 28 days unless the manufacturer specifies a different (shorter or longer) date for
that opened vial.
• 	If	a	multi-dose	vial	has	not	been	opened	or	accessed	(e.g.,	needle-punctured),	it	should	be
discarded according to the manufacturer’s expiration date.
The manufacturer’s expiration date refers to the date after which an unopened multi-dose vial should not 
be used. The beyond-use-date refers to the date after which an opened multi-dose vial should not be used. 
The beyond-use-date should never exceed the manufacturer’s original expiration date. 
For	information	on	storage	and	handling	of	vaccines	please	refer	to	the	CDC	Vaccine	Storage	and	
Handling Toolkit: http://www2a.cdc.gov/vaccines/ed/shtoolkit/ or the manufacturer’s recommendations 
for specific vaccines.
Source: Centers for Disease Control and Prevention, December 2010, http://www.cdc.gov/injectionsafety/providers/provider_faqs.html
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The	Safe	Injection	Practices	Coalition	(SIPC)	is	a	partnership	of	healthcare-related	organizations	led	by	the	
Centers for Disease Control and Prevention. The SIPC developed the One & Only Campaign—a public  
health effort to eliminate unsafe medical injections by raising awareness of safe injection practices.  
For	a	list	of	SIPC	Partners,	more	information	about	the	Campaign,	and	to	view	additional	resources	
including videos and other materials, please visit:
OneandOnlyCampaign.org
For	the	latest	news	and	updates,	follow	us	on	 
Twitter	@injectionsafety	and	Facebook/OneandOnlyCampaign.
This	material	was	developed	by	CDC.	The	One & Only Campaign	is	made	possible	 
by	partnership	between	the	CDC	Foundation	and	Lilly	USA,	LLC.
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• Implement the use of universal precautions
(treating all human blood and OPIM as if known
to be infectious for bloodborne pathogens).
• Identify and use engineering controls. These
are devices that isolate or remove the blood-
borne pathogens hazard from the workplace.
They include sharps disposal containers, self-
sheathing needles, and safer medical devices,
such as sharps with engineered sharps-injury
protection and needleless systems.
• Identify and ensure the use of work practice
controls. These are practices that reduce the
possibility of exposure by changing the way a
task is performed, such as appropriate practices
for handling and disposing of contaminated
sharps, handling specimens, handling laundry,
and cleaning contaminated surfaces and items.
• Provide personal protective equipment (PPE),
such as gloves, gowns, eye protection, and
masks. Employers must clean, repair, and
replace this equipment as needed. Provision,
maintenance, repair and replacement are at no
cost to the worker.
• Make available hepatitis B vaccinations to all
workers with occupational exposure. This vac-
cination must be offered after the worker has
received the required bloodborne pathogens
training and within 10 days of initial assignment
to a job with occupational exposure.
• Make available post-exposure evaluation and
follow-up to any occupationally exposed work-
er who experiences an exposure incident. An
exposure incident is a specific eye, mouth,
other mucous membrane, non-intact skin, or
parenteral contact with blood or OPIM. This
evaluation and follow-up must be at no cost to
the worker and includes documenting the
route(s) of exposure and the circumstances
Protections Provided by OSHA’s
Bloodborne Pathogens Standard
All of the requirements of OSHA’s Bloodborne
Pathogens standard can be found in Title 29 of the
Code of Federal Regulations at 29 CFR 1910.1030.
The standard’s requirements state what employ-
ers must do to protect workers who are occupa-
tionally exposed to blood or other potentially
infectious materials (OPIM), as defined in the stan-
dard. That is, the standard protects workers who
can reasonably be anticipated to come into con-
tact with blood or OPIM as a result of doing their
job duties.  
In general, the standard requires employers to:
• Establish an exposure control plan. This is a
written plan to eliminate or minimize occupa-
tional exposures. The employer must prepare
an exposure determination that contains a list
of job classifications in which all workers have
occupational exposure and a list of job classifi-
cations in which some workers have occupa-
tional exposure, along with a list of the tasks
and procedures performed by those workers
that result in their exposure.
• Employers must update the plan annually to
reflect changes in tasks, procedures, and posi-
tions that affect occupational exposure, and
also technological changes that eliminate or
reduce occupational exposure. In addition,
employers must annually document in the plan
that they have considered and begun using
appropriate, commercially-available effective
safer medical devices designed to eliminate or
minimize occupational exposure. Employers
must also document that they have solicited
input from frontline workers in identifying, eval-
uating, and selecting effective engineering and
work practice controls.
FactSheet
OSHA’s Bloodborne Pathogens Standard
Bloodborne pathogens are infectious microorganisms present in blood that can
cause disease in humans. These pathogens include, but are not limited to, hepatitis B
virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV), the
virus that causes AIDS. Workers exposed to bloodborne pathogens are at risk for
serious or life-threatening illnesses. 
21
This is one in a series of informational fact sheets highlighting OSHA programs, policies or 
standards. It does not impose any new compliance requirements. For a comprehensive list of 
compliance requirements of OSHA standards or regulations, refer to Title 29 of the Code of Federal
Regulations.  This information will be made available to sensory-impaired individuals upon request.
The voice phone is (202) 693-1999; the teletypewriter (TTY) number is (877) 889-5627.
under which the exposure incident occurred;
identifying and testing the source individual for
HBV and HIV infectivity, if the source individual
consents or the law does not require consent;
collecting and testing the exposed worker’s
blood, if the worker consents; offering post-
exposure prophylaxis; offering counseling; and
evaluating reported illnesses. The healthcare
professional will provide a limited written opin-
ion to the employer and all diagnoses must
remain confidential.
• Use labels and signs to communicate hazards.
Warning labels must be affixed to containers
of regulated waste; containers of contaminated
reusable sharps; refrigerators and freezers
containing blood or OPIM; other containers
used to store, transport, or ship blood or OPIM;
contaminated equipment that is being shipped
or serviced; and bags or containers of con-
taminated laundry, except as provided in the
standard. Facilities may use red bags or red
containers instead of labels. In HIV and HBV
research laboratories and production facilities,
signs must be posted at all access doors when
OPIM or infected animals are present in the
work area or containment module.
• Provide information and training to workers.
Employers must ensure that their workers
receive regular training that covers all elements
of the standard including, but not limited to:
information on bloodborne pathogens and dis-
eases, methods used to control occupational
exposure, hepatitis B vaccine, and medical eval-
uation and post-exposure follow-up procedures.
Employers must offer this training on initial
assignment, at least annually thereafter, and
when new or modified tasks or procedures
affect a worker’s occupational exposure. Also,
HIV and HBV laboratory and production facility
workers must receive specialized initial training,
in addition to the training provided to all work-
ers with occupational exposure. Workers must
have the opportunity to ask the trainer ques-
tions.  Also, training must be presented at an
educational level and in a language that work-
ers understand.  
• Maintain worker medical and training records.
The employer also must maintain a sharps
injury log, unless it is exempt under Part 1904 --
Recording and Reporting Occupational Injuries
and Illnesses, in Title 29 of the Code of Federal
Regulations.
Additional Information
For more information, go to OSHA’s Bloodborne
Pathogens and Needlestick Prevention Safety and
Health Topics web page at: https://www.osha.gov/
SLTC/bloodbornepathogens/index.html.
To file a complaint by phone, report an emergency,
or get OSHA advice, assistance, or products, con-
tact your nearest OSHA office under the “U.S.
Department of Labor” listing in your phone book, or
call us toll-free at (800) 321-OSHA (6742). 
Occupational Safety
and Health Administration
www.osha.gov  1-800-321-6742
For assistance, contact us. We can help. It’s confidential.
DSG 1/2011
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they show signs of cracking, peeling, tearing,
puncturing, or deteriorating. Non-latex gloves,
glove liners, powderless gloves or similar alterna-
tives must be provided if workers are allergic to
the gloves normally provided.
Gloves are required for all phlebotomies outside
of volunteer blood donation centers. If an employ-
er in a volunteer blood donation center judges
that routine gloving for all phlebotomies is not
necessary, then the employer is required to peri-
odically re-evaluate this policy; make gloves avail-
able for workers who want to use them; and can-
not discourage their use. In addition, employers
must ensure that workers in volunteer blood
donation centers use gloves (1) when they have
cuts, scratches or other breaks in their skin, (2)
while they are in training, or (3) when the worker
believes that hand contamination might occur. 
When splashes, sprays, splatters, or droplets of
blood or OPIM pose a hazard to the eyes, nose 
or mouth, then masks in conjunction with eye
protection (such as goggles or glasses with solid
side shields) or chin-length face shields must be
worn. Protection against exposure to the body is
provided by protective clothing, such as gowns,
aprons, lab coats, and similar garments.  Surgical
caps or hoods, and shoe covers or boots are
needed when gross contamination is expected,
such as during orthopedic surgery or autopsies. 
In HIV and HBV research laboratories and produc-
tion facilities, laboratory coats, gowns, smocks,
uniforms, or other appropriate protective clothing
must be used in work areas and animal rooms.
Also, protective clothing must not be worn outside
of the work area and must be decontaminated
before being laundered.
One way the employer can protect workers
against exposure to bloodborne pathogens, such
as hepatitis B virus (HBV), hepatitis C virus (HCV),
and human immunodeficiency virus (HIV), the
virus that causes AIDS, is by providing and
ensuring they use personal protective equipment,
or PPE. Wearing appropriate PPE can significantly
reduce risk, since it acts as a barrier against
exposure. Employers are required to provide,
clean, repair, and replace this equipment as
needed, and at no cost to workers.
Selecting Personal Protective
Equipment
Personal protective equipment may include
gloves, gowns, laboratory coats, face shields or
masks, eye protection, pocket masks, and other
protective gear. The PPE selected must be appro-
priate for the task. This means the level and type
of protection must fit the expected exposure. For
example, gloves may be the only PPE needed for
a laboratory technician who is drawing blood.
However, a pathologist conducting an autopsy
would need much more protective clothing
because of the different types of exposure (e.g.,
splashes, sprays) and the increased amount of
blood and OPIM that are encountered. PPE must
be readily accessible to workers and available in
appropriate sizes.
If it can be reasonably expected that a worker
could have hand contact with blood, OPIM, or
contaminated surfaces or items, the employer
must ensure that the worker wears gloves. Single-
use gloves cannot be washed or decontaminated
for reuse. Utility gloves may be decontaminated
if their ability to provide an effective barrier is not
compromised. They should be replaced when
FactSheet
Personal Protective Equipment (PPE)
Reduces Exposure to Bloodborne Pathogens
OSHA’s Bloodborne Pathogens standard (29 CFR 1910.1030) requires employers to
protect workers who are occupationally exposed to blood and other potentially
infectious materials (OPIM), as defined in the standard. That is, the standard protects
workers who can reasonably be anticipated to come into contact with blood or
OPIM as a result of doing their job duties.
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Exception to Use of Personal Protective
Equipment
A worker may choose, temporarily and briefly,
under rare and extraordinary circumstances, to
forego use of personal protective equipment. It
must be the worker’s professional judgment that
using the personal protective equipment would
prevent the delivery of health care or public safety
services or would pose an increased hazard to 
the safety of the worker or coworker. When such 
a situation occurs, the employer is required to
investigate and document the circumstances 
to determine if there is a way to avoid it from 
happening again in the future. Employers and
workers should be aware that this is not a blanket
exemption to the requirement to use PPE. OSHA
expects that this will be an extremely rare occur-
rence.
Decontaminating and Disposing of
Personal Protective Equipment
Employers must ensure that workers remove 
personal protective equipment before leaving the
work area. If a garment is penetrated by blood or
OPIM, it must be removed immediately or as soon
as feasible. Once PPE is removed, it must be
placed in an appropriately designated area or 
container for storage, washing, decontamination,
or disposal.  In addition, employers must ensure
that workers wash their hands immediately or as
soon as feasible after removal of gloves or other
personal protective equipment.
Additional Information
For more information, go to OSHA’s Bloodborne
Pathogens and Needlestick Prevention Safety and
Health Topics web page at:  https://www.osha.gov/
SLTC/bloodbornepathogens/index.html.
To file a complaint by phone, report an emergency,
or get OSHA advice, assistance, or products, con-
tact your nearest OSHA office under the “U.S.
Department of Labor” listing in your phone book, or
call us toll-free at (800) 321-OSHA (6742). 
Occupational Safety
and Health Administration
www.osha.gov  1-800-321-6742
For assistance, contact us. We can help. It’s confidential.
DSG 1/2011
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Guidance for Blood Glucose Monitoring 
and Insulin Administration
25
Unsafe Practices During Blood Glucose Monitoring 
and Insulin Administration
Best Practices for Assisted Blood Glucose Monitoring and Insulin Administration
An underappreciated risk of blood glucose testing is the opportunity for exposure to bloodborne viruses 
(HBV, hepatitis C virus, and HIV) through contaminated equipment and supplies if devices used for testing 
and/or insulin administration (e.g., blood glucose meters, fingerstick devices, insulin pens) are shared.
Outbreaks of hepatitis B virus (HBV) infection associated with blood glucose monitoring have been identified 
with increasing regularity, particularly in long-term care settings, such as nursing homes and assisted living 
facilities, where residents often require assistance with monitoring of blood glucose levels and/or insulin 
administration. Although the majority of these outbreaks have been reported in long-term care settings, the 
risk of infection is present in any setting where blood glucose monitoring equipment is shared or those assisting 
with blood glucose monitoring and/or insulin administration fail to follow basic principles of infection control.
The following are infection control recommendations based on CDC guidelines that anyone who performs 
or assists with blood glucose monitoring and /or insulin administration should review to assure they are not 
placing themselves or persons in their care at risk:
Lancets
Restrict use of fingerstick devices 
to individual persons. They should 
never be used for more than one 
person. Select single-use lancets that 
permanently retract upon puncture. 
This adds an extra layer of safety for 
the patient and the provider.
Dispose of used lancets at the 
point of use in an approved sharps 
container. Never reuse lancets.
Blood Glucose Meters
Whenever possible, blood glucose 
meters should be assigned to an 
individual person and not be shared.
If blood glucose meters must 
be shared, the device should be 
cleaned and disinfected after every 
use, per manufacturer’s instructions, 
to prevent carry-over of blood and 
infectious agents. If the manufacturer 
does not specify how the device 
should be cleaned and disinfected 
then it should not be shared.
Insulin Administration
Insulin pens should be assigned 
to individual persons and labeled 
appropriately. They should never be 
used for more than one person.
Multiple-dose vials of insulin 
should be dedicated to a single 
person whenever possible. If the 
vial must be used for more than 
one person it should be stored and 
prepared in a dedicated medication 
preparation area outside of the 
patient care environment and away 
from potentially contaminated 
equipment.
Medication vials should always be 
entered with a new needle and 
new syringe. Never reuse needles or 
syringes.
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Background 
Insulin pens are pen-shaped injector devices that contain a reservoir for insulin or an insulin 
cartridge. These devices are designed to permit self-injection and are intended for single- 
person use. In healthcare settings, these devices are often used by healthcare personnel 
to administer insulin to patients. Insulin pens are designed to be used multiple times, for a  
single person, using a new needle for each injection. Insulin pens must never be used for more than one person. 
Regurgitation of blood into the insulin cartridge can occur after injection [1] creating a risk of bloodborne pathogen 
transmission if the pen is used for more than one person, even when the needle is changed.  
In 2009, in response to reports of improper use of insulin pens in hospitals, the Food and Drug Administration (FDA) issued 
an alert for healthcare professionals reminding them that insulin pens are meant for use on a single patient only and are not 
to be shared between patients [2]. In spite of this alert, there have been continuing reports of patients placed at risk through 
inappropriate reuse and sharing of insulin pens, including an incident in 2011 that required notification of more than 2,000 
potentially exposed patients [3]. These events indicate that some healthcare personnel do not adhere to safe practices and 
may be unaware of the risks these unsafe practices pose to patients.  
Recommendations 
Anyone using insulin pens should review the following recommendations to ensure that they are not placing persons in their 
care at risk for infection.  
• Insulin pens containing multiple doses of insulin are meant for use on a single person only, and should never be
used for more than one person, even when the needle is changed.
• Insulin pens should be clearly labeled with the person’s name or other identifying information to ensure that the
correct pen is used only on the correct individual.
• Hospitals and other facilities should review their policies and educate their staff regarding safe use of insulin pens
and similar devices.
• If reuse is identified, exposed persons should be promptly notified and offered appropriate follow-up including
bloodborne pathogen testing.
These recommendations apply to any setting where insulin pens are used, including assisted living or residential care 
facilities, skilled nursing facilities, clinics, health fairs, shelters, detention facilities, senior centers, schools, and camps as well 
as licensed healthcare facilities. Protection from infections, including bloodborne pathogens, is a basic expectation anywhere 
healthcare is provided. Use of insulin pens for more than one person, like other forms of syringe reuse [4], imposes 
unacceptable risks and should be considered a 'never event'.  
See additional information on assuring safe care during blood glucose monitoring and insulin administration. 
References 
1. Sonoki K, Yoshinari M, Iwase M, Tashiro K, Iino K, Wakisaka M, Fujishima M. Regurgitation of blood into insulin cartridges
in the pen-like injectors. Diabetes Care. 2001;24(3):603-4.
2. Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens
(2009). U.S. Food and Drug Administration Postmarket Drug Safety Information for Patients and Providers.
3. Important Patient Safety Notification (2011). Dean Clinic.
4. Centers for Disease Control and Prevention (CDC) and the Safe Injection Practices Coalition (SIPC)
CDC CLINICAL REMINDER 
Insulin Pens 
Must Never Be Used for More than One Person 
Summary 
The Centers for Disease Control and Prevention (CDC) has become increasingly aware of 
reports of improper use of insulin pens, which places individuals at risk of infection with 
pathogens including hepatitis viruses and human immunodeficiency virus (HIV). This notice 
serves as a reminder that insulin pens must never be used on more than one person. 
 
National Center for Emerging and Zoonotic Infectious Diseases 
Division of Healthcare Quality Promotion (DHQP)  
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Blood Glucose Monitoring Safety Checklist
Step 1
• Regularly review each patient’s schedules for fingerstick blood glucose sampling to reduce the number of percutaneous procedures to
the minimum necessary for appropriate medical management of diabetes and its complications.
Step 2
• Decontaminate blood glucose monitor regularly prior to use and anytime surfaces become contaminated with blood or body fluids.
Step 3
• Restrict use of fingerstick capillary blood sampling devices to individual patients. Consider selecting single-use lancets that
permanently retract upon puncture.
Step 4
• Assign glucometers to individual patients. If a blood glucose meter must be used for multiple patients, the device must be cleaned and
disinfected between each patient use.
Step 5
• Perform hand hygiene (i.e., handwashing with soap and water or use of an alcohol-based hand rub) prior to procedure.
Step 6
• Wear gloves during fingerstick glucose monitoring and during any other procedure that involves potential exposure to blood or bodily
fluids. Perform hand hygiene after removal of gloves.
Step 7
• Dispose of used fingerstick devices and lancets at the point of use in an approved sharps container.
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Insulin Administration Safety Checklist
Step 1
•Ensure that injection equipment (i.e., insulin pens, needles, and syringes) should never be used for more than one person.
Step 2
•Assign insulin pens to individual persons and label with the person’s name or other identifying information to ensure that the correct pen is
used only on the correct individual.
Step 3
•Dedicate multiple-dose vials of insulin to a single person whenever possible. If the vial must be used for more than one person it should be stored and
prepared in a dedicated medication preparation area outside of the patient care environment and away from potentially contaminated equipment.
•Always enter medication vials with a new needle and syringe with every individual.
Step 4
•Check the expiration date of insulin prior to administration.
Step 5
•Verify dosage recommendation according to physician/pharmacy order for administration based on the individual’s blood glucose result.
Step 6
•Perform hand hygiene prior to and after insulin administration.
Step 7
•Dispose of needles in an approved sharps container.
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Training
30
Safe Injection Training and Oversight for Healthcare Staff
1. Establish responsibility for oversight of infection control activities.
Investigate and report any suspected case that may represent a newly acquired
blood-borne infection.
2. Have staff demonstrate knowledge of standard precautions guidelines
and proficiency in application of these guidelines during procedures that involve 
possible blood or body fluid exposures.
3. Provide staff members who assume responsibilities involving
percutaneous procedures with infection control training that includes practical
demonstration of aseptic techniques and instruction regarding reporting
exposures or breaches. Direct annual retraining to all staff members who perform
procedures that involve exposure to blood or body fluids.
4. Assess compliance with infection control recommendations for fingerstick glucose
monitoring (such as hand hygiene and glove changes between patients) by
periodically observing personnel and tracking use of supplies.
5. Provide a full hepatitis B vaccination series to all previously unvaccinated
staff persons whose activities involve contact with blood or body fluids. Check
and document post-vaccination titers one to two months after completion of the
vaccination series.
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Injection Safety!
Every Providerʼs Responsibility!
Outline!
•  Safe Injection Practices"
•  The ONE and ONLY Campaign"
•  Outbreak History"
•  Mistaken Beliefs"
•  A Call to Action"
•  Resources and Information"
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Why Unsafe Injection Practices 
Are Unacceptable!
•  Injection safety is part of Standard
Precautions"
•  Healthcare practices should notprovide a
pathway for transmission of life-threatening
infections"
•  Patient protections regarding injection
safety should be on par with healthcare
worker safety"
Three Things Every Provider Needs 
to Know About Injection Safety!
1. Needles and syringes are single use devices.
They should not be used for more than one patient
or reused to draw up additional medication."
2. Do not administer medications from a single-dose
vial or IV bag to multiple patients."
3. Limit the use of multi-dose vials and dedicate them
to a single patient whenever possible."
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Evelyn McKnightʼs Story!
Dr. Evelyn McKnight, mother of three, was  
battling breast cancer and was infected with  
hepatitis C during treatment because of  
syringe reuse to access saline flush solution."
Along with Evelyn, a total of 99 cancer patients were 
infected in what was one of the largest outbreaks of  
hepatitis C in American healthcare history."
Evelyn co-founded HONOReform, a foundation  
dedicated to improving Americaʼs injection safety  
practices, and was the catalyst of the formation of the  
Safe Injection Practices Coalition."
The ONE and ONLY Campaign!
•  Launched in response to outbreaks
resulting from unsafe injection practices"
•  Led by the Centers for Disease Control
and Prevention (CDC) and the Safe
Injection Practices Coalition"
•  Goals"
– Increase understanding and implementation of
safe injection practices among healthcare
providers"
–  Ensure patients are protected each and every
time they receive a medical injection"
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U.S.  Outbreaks  Associatedwith
Unsafe  Injection  Practices,  2001-­2011
Bacterial
Viral
Over 125,000 patients were notified as a result of incidents 
and outbreaks involving unsafe injections practices "
City  alerts   450   patients   of  Hylan  
Boulevard   clinic   to  hepatitis   C    
Concern
June  17, 2011
Parents’   horror  as  they   are  told to  
test   their   infants   for  HIV  after   flu     
vaccine mix-­up
April  13, 2011
Nurse  accused of  
stealing
pain   meds  gets probation
September   20, 2011
NJ  doctor   loses   license  
after   hepatitis   B  outbreak  
September   15, 2011
Guh, A et al. “Patie nt Notific ation for Bloodb orn e Pat hoge n Testing Du e to Unsaf e Inj ection Practic es in U.S. Healthc are Settings , 19 99– 2009. ” Fifth D ecen nia l
Inter nation al Con fer ence on He althca re-Associ ated Infec tions. Cent ers f or Dis ease C ontr ol an d Prev entio n, Atla nta, GA. 20 Ma rch 201 0. Ret rieved fr om http:/ /
shea.confex.com/shea/2010/we bpro gra m/Pape r17 89.ht ml."
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Injection Practices Among Clinicians in  
United States Health Care Settings!
•  Survey of 5,500 U.S. healthcare professionals "
•  1 percent “sometimes or always” reuse a syringe
on a second patient "
•  1 percent “sometimes or always” reuse a
multidose vial for additional patients after
accessing itwith a used syringe "
•  6 percent use single-dose/single use vials for
more than one patient"
Pugliese G., Gosnell C., Bartley J., & Robinson S. (December 2010). Injection practices among clinicians in United States health care settings. American Journal of  
Infection Control, 38 (10), 789-798. Retrieved from http://www.ajicjournal.org/article/PIIS0196 6553 1000 8539 /abst ract. "
When Safe Practices are Used…!
Each Patient is an Island!
SOURCE!
Infectious person,"
e.g. chronic, acute"
HOST
Susceptible, "
non-immune person"
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Unsafe Injection Practices Can Lead to  
Transmission of Life-Threatening Infections!
SOURCE!
Infectious person,"  
e.g., chronic, acute"
CONTAMINATED 
NEEDLE OR  
MEDICATION!
HOST
Susceptible, "
non-immune person"
LIMIT OR ELIMINATE REUSE!
Las Vegas, Nevada Outbreak, 2008!
•  Cluster of three acute HCV infections identified in
Las Vegas"
•  All three patients underwent procedures at the same
endoscopy clinic during the incubation period"
•  Two breaches contributed to transmission:"
– Re-entering vials with used syringes"
–  Using contents from these single-dose vials on more than
one patient"
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Las Vegas, Nevada Outbreak, 2008!
Adapted from MMWR (May 16, 2008 / 57(19);513-517)"
Insulin Pen Reuse Incidents!
•  Reuse of insulin pens for multiple patients,
reportedly after changing needles has resulted in
large notifications"
– NY hospital, 2008: 185 patients notified"
– TX hospital, 2009: 2,114 patients notified"
– WI hospital and outpatient clinic, 2011:
2,401 patients notified"
Infection Prevention during Blood Glucose Monitoring and Insulin Administration (2012). Retrieved March 9, 2012 from http://www.cdc.gov/injectionsafety/blood-glucose-monitoring.html" 
Important Patient Safety Notification (2011). Retrieved March 9, 2012 from http://www.deancare.com/about-dean/news/2011/importa nt-patient -safety- notification/"
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True or False?!
“Iʼm preventing contamination and infection 
transmission as long as Iʼm…”!
“…changing the needle between patients.”" FALSE!
“…injecting through intervening lengths 
of intravenous tubing.”" FALSE!
“…maintaining pressure on the plunger 
to prevent backflow of body fluids.”" FALSE!
“…not able to observe contamination 
or blood.”" FALSE!
Unsafe  Injection  Practices  Result In…
• Patients placed  at  risk  for  life threatening infections
• Referral o f   p r o v i d e r s   t o   l i c e n s i n g   b o a r d s   f o r   d i s c i p l i n a r y  
action
• Legal  actions  such  as  malpractice  suits  filed  by patients
• CMS  and  The  Joint  Commission  have begun assessing
injection   practices  as  part  of  facility inspections
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A Call to Action!
•  Injection practices should
not provide a pathway for
transmission of life-
threatening infections"
•  Injection safety is every
providerʼs responsibility"
•  Safe injection practices
should be discussed and
reviewed frequently among
colleagues"
Injection Safety Checklist!
www.cdc.gov/injectionsafety"
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Resources and Information!
www.cdc.gov/injectionsafety!
ONEandONLYcampaign.org!
Materials Available for Order!
1-800-CDC-INFO"
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Promotional Materials
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Injection Safety
Guidelines 
 
from the 
Centers for Disease 
Control and Prevention
Injection Safety Guidelines From CDC
■  Never administer medications from the same syringe to
more than one patient, even if the needle is changed.
■  After a syringe or needle has been used to enter or
connect to a patient’s IV it is contaminated and should not
be used on another patient or to enter a medication vial.
■ Never enter a vial with a used syringe or needle.
■  Never use medications packaged as single-dose vials for
more than one patient.
■  Assign medications packaged as multi-dose vials to a
single patient whenever possible.
■  Do not use bags or bottles of intravenous solution as a
common source of supply for more than one patient.
■  Follow proper infection control practices during the
preparation and administration of injected medications.
■  Wear a surgical mask when placing a catheter or injecting
material into the spinal canal or subdural space.
Adapted from: Guideline for isolation precautions: preventing transmission 
of infectious agents in health care settings 2007. Atlanta, GA: US Department 
of Health and Human Services, CDC; 2007. Available at: http://www. cdc.gov/
hicpac/pdf/isolation/isolation2007.pdf
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INJECTION SAFETY        CHECKLIST
The following Injection Safety checklist items are a subset of items that can be found in the CDC Infection Prevention Checklist for 
Outpatient Settings: Minimum Expectations for Safe Care.  
The checklist, which is appropriate for both inpatient and outpatient settings, should be used to systematically assess adherence 
of healthcare personnel to safe injection practices. (Assessment of adherence should be conducted by direct observation of 
healthcare personnel during the performance of their duties.) 
Injection Safety
Practice 
Performed?
If answer is No, document plan 
for remediation
Injections are prepared using aseptic technique in a 
clean area free from contamination or contact with 
blood, body fluids or contaminated equipment.
Yes  No
Needles and syringes are used for only one patient 
(this includes manufactured prefilled syringes and 
cartridge devices such as insulin pens).
Yes  No
The rubber septum on a medication vial is 
disinfected with alcohol prior to piercing Yes  No
Medication vials are entered with a new needle 
and a new syringe, even when obtaining additional 
doses for the same patient.
Yes  No
Single dose (single-use) medication vials, ampules, 
and bags or bottles of intravenous solution are used 
for only one patient.
Yes  No
Medication administration tubing and connectors 
are used for only one patient. Yes  No
Multi-dose vials are dated by HCP when they are 
first opened and discarded within 28 days unless the 
manufacturer specifies a different (shorter or longer) 
date for that opened vial.
Note: This is different from the expiration date printed on the vial.
Yes    No
Multi-dose vials are dedicated to individual patients 
whenever possible. Yes    No
Multi-dose vials to be used for more than one 
patient are kept in a centralized medication area 
and do not enter the immediate patient treatment 
area (e.g,. operating room, patient room/cubicle).
Note: If multi-dose vials enter the immediate patient treatment 
area they should be dedicated for single-patient use and 
discarded immediately after use.
Yes    No
RESOURCES
Checklist: http://www.cdc.gov/HAI/pdfs/guidelines/ambulatory-care-checklist-07-2011.pdf 
Guide to Infection Prevention for Outpatient Settings: Minimum Expectations for Safe Care:  
http://www.cdc.gov/HAI/pdfs/guidelines/standatds-of-ambulatory-care-7-2011.pdf 
www.oneandonlycampaign.org 44
The One & Only Campaign is a public health ef fort to 
eliminate unsafe medical injections. To learn more 
about safe injection practices, please visit 
OneandOnlyCampaign.org. 
This material was developed by CDC. The One & Only Campaign is made possible by a partnership between the CDC Foundation and Lilly USA, LLC.
For the latest news and updates, follow us on Twitter 
@injectionsafety and Facebook/OneandOnlyCampaign.
Patients and healthcare providers must 
insist on nothing less than One Needle, 
One Syringe, Only One Time for each
and every injection.
OneandOnlyCampaign.org
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Multimedia Links
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Multimedia	  Links	  
Injection	  Safety	  PowerPoint Video:	  
Videos:	  
Check	  Your	  Steps!	  Make	  Every	  Injection	  Safe	  [3:15	  mins]	  
Managing	  Patient	  Safety,	  One	  Injection	  at	  a	  Time	  [2:35	  mins]	  
Safe	  Injection	  Practices	  –	  How	  to	  Do	  it	  Right	  [4:25	  mins]	  
Safe	  Injection	  Practices:	  A	  Video	  for	  Healthcare	  Providers	  [13:01	  mins]	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For	  more	  information,	  please	  visit	  One	  and	  
Only	  Campaign	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